NYSE:CLB - Core Laboratories Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $70.50 +2.22 (+3.25 %) (As of 01/18/2019 04:00 PM ET)Previous Close$70.50Today's Range$68.68 - $71.4652-Week Range$56.72 - $130.34Volume558,874 shsAverage Volume612,107 shsMarket Capitalization$3.02 billionP/E Ratio35.25Dividend Yield3.22%Beta1.83 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands. Receive CLB News and Ratings via Email Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Oil & gas field services, not elsewhere classified Sub-IndustryN/A SectorOils/Energy Current SymbolNYSE:CLB Previous Symbol CUSIPN/A Webwww.corelab.com Phone31-20-420-3191Debt Debt-to-Equity Ratio1.83 Current Ratio2.31 Quick Ratio1.85Price-To-Earnings Trailing P/E Ratio35.25 Forward P/E Ratio30.92 P/E Growth3.32 Sales & Book Value Annual Sales$659.81 million Price / Sales4.72 Cash Flow$2.6504 per share Price / Cash Flow26.60 Book Value$3.37 per share Price / Book20.92Profitability EPS (Most Recent Fiscal Year)$2.00 Net Income$83.12 million Net Margins13.21% Return on Equity68.00% Return on Assets17.17%Miscellaneous Employees4,600 Outstanding Shares44,220,000Market Cap$3.02 billion OptionableOptionable Core Laboratories (NYSE:CLB) Frequently Asked Questions What is Core Laboratories' stock symbol? Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB." How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories? Core Laboratories declared a quarterly dividend on Wednesday, January 16th. Stockholders of record on Friday, January 25th will be given a dividend of $0.55 per share on Friday, February 15th. This represents a $2.20 annualized dividend and a dividend yield of 3.12%. The ex-dividend date is Thursday, January 24th. View Core Laboratories' Dividend History. How were Core Laboratories' earnings last quarter? Core Laboratories (NYSE:CLB) posted its quarterly earnings data on Wednesday, October, 24th. The oil and gas company reported $0.64 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.63 by $0.01. The oil and gas company had revenue of $182.15 million for the quarter, compared to analyst estimates of $178.11 million. Core Laboratories had a net margin of 13.21% and a return on equity of 68.00%. Core Laboratories's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.46 earnings per share. View Core Laboratories' Earnings History. When is Core Laboratories' next earnings date? Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January 30th 2019. View Earnings Estimates for Core Laboratories. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories issued an update on its fourth quarter earnings guidance on Wednesday, October, 24th. The company provided EPS guidance of $0.48-0.54 for the period, compared to the Thomson Reuters consensus estimate of $0.59. The company issued revenue guidance of $173-176 million, compared to the consensus revenue estimate of $174.91 million.Core Laboratories also updated its Q4 2018 guidance to $0.48-0.54 EPS. What price target have analysts set for CLB? 13 brokers have issued 12 month target prices for Core Laboratories' shares. Their forecasts range from $66.00 to $130.00. On average, they anticipate Core Laboratories' stock price to reach $93.00 in the next year. This suggests a possible upside of 31.9% from the stock's current price. View Analyst Price Targets for Core Laboratories. What is the consensus analysts' recommendation for Core Laboratories? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories. Has Core Laboratories been receiving favorable news coverage? Media stories about CLB stock have been trending somewhat positive recently, InfoTrie reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Core Laboratories earned a news impact score of 1.7 on InfoTrie's scale. They also gave headlines about the oil and gas company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. Who are some of Core Laboratories' key competitors? Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), SemGroup (SEMG), Franks International (FI), C&J Energy Services (CJ), Mammoth Energy Services (TUSK), Helix Energy Solutions Group (HLX), Keane Group (FRAC), Select Energy Services (WTTR), FTS International (FTSI), National Energy Services (NESR), Hurricane Energy (HRCXF) and KLX Energy Services (KLXE). Who are Core Laboratories' key executives? Core Laboratories' management team includes the folowing people: Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)Mr. Monty L. Davis, COO & Sr. VP (Age 65)Mr. Richard L. Bergmark, Exec. VP (Age 66)Mr. Lawrence V. Bruno, Pres & Supervisory Director (Age 59)Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49) Who are Core Laboratories' major shareholders? Core Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BTIM Corp. (0.15%), Douglas Lane & Associates LLC (0.13%), Retirement Systems of Alabama (0.13%), Gofen & Glossberg LLC IL (0.07%), Arcadia Investment Management Corp MI (0.04%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Kevin Daniels, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories. Which institutional investors are selling Core Laboratories stock? CLB stock was sold by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Arcadia Investment Management Corp MI, BTIM Corp. and Louisiana State Employees Retirement System. View Insider Buying and Selling for Core Laboratories. Which institutional investors are buying Core Laboratories stock? CLB stock was acquired by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC and Retirement Systems of Alabama. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories. How do I buy shares of Core Laboratories? Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Core Laboratories' stock price today? One share of CLB stock can currently be purchased for approximately $70.50. How big of a company is Core Laboratories? Core Laboratories has a market capitalization of $3.02 billion and generates $659.81 million in revenue each year. The oil and gas company earns $83.12 million in net income (profit) each year or $2.00 on an earnings per share basis. Core Laboratories employs 4,600 workers across the globe. What is Core Laboratories' official website? The official website for Core Laboratories is http://www.corelab.com. How can I contact Core Laboratories? Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected] MarketBeat Community Rating for Core Laboratories (NYSE CLB)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 371 (Vote Outperform)Underperform Votes: 511 (Vote Underperform)Total Votes: 882MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: What is intrinsic value?